NRAS and melanoma: It has been identified as a specific marker with relatively high sensitivity and specificity for the diagnosis of melanocytic and Schwannian tumors, including metastatic melanoma occurring in sentinel lymph nodes.61–63 Preliminary studies have demonstrated that haplo-insufficiency of SOX10 inhibits mutant NRAS-driven formation of congenital nevus and melanoma in transgenic mice model.